Austar Lifesciences : Announcements and Notices – Interim Results

Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.

Austar Lifesciences Limited

奧星生命科技有限公司

(Incorporated in the Cayman Islands with limited liability)

(Stock Code: 6118)

ANNOUNCEMENT OF INTERIM RESULTS FOR THE SIX MONTHS ENDED 30 JUNE 2017

GROUP FINANCIAL HIGHLIGHTS

For the six months ended

30 June

2017 2016

RMB'000 RMB'000

(Unaudited) (Unaudited)

Revenue

Gross profit

Loss before income tax

Loss attributable to the owners of the Company Gross profit margin

Basic loss per share (RMB) (Note)

Diluted loss per share (RMB)

244,852

45,503

(26,894)

(25,097)

18.6%

(0.05)

(0.05)

289,837

73,572

(12,898)

(12,126)

25.4%

(0.02)

(0.02)

As at

30 June

2017

RMB'000

(Unaudited)

As at

31 December

2016

RMB'000

(Audited)

Total assets

Net assets Gearing ratio

859,552

514,902

5.4%

914,776

546,115

3.7%

Note: The calculation of loss per share is based on the loss attributable to the owners of the

Company for each of the six months ended 30 June 2017 and 2016 and the weighted average number of shares during that period.

INTERIM RESULTS

The board ("Board") of directors ("Directors") of Austar Lifesciences Limited ("Company" or "Austar", together with its subsidiaries, the "Group") announces the unaudited condensed consolidated interim results of the Group for the six months ended 30 June 2017 ("Period under Review"), together with the comparative figures for the corresponding period in 2016 as follows:

CONDENSED CONSOLIDATED INTERIM STATEMENT OF INCOME

For the six months ended 30 June

Note	2017 RMB'000 (Unaudited)	2016 RMB'000 (Unaudited)
Revenue	3	244,852	289,837
Cost of sales	(199,349)	(216,265)
Gross profit	45,503	73,572
Other income	2,206	978
Other gains/(losses)	1,748	(2,117)
Selling and marketing expenses	(40,726)	(40,163)
Administrative expenses	(28,983)	(31,773)
Research and development expenses	(12,397)	(16,552)
Operating loss	(32,649)	(16,055)
Interest income	2,362	2,254
Finance expenses	(148)	(978)
Finance income - net	4	2,214	1,276
Share of profit of investments accounted for using the equity method	3,541	1,881
Loss before income tax	(26,894)	(12,898)
Income tax credit	5	1,797	772
Loss for the period	(25,097)	(12,126)
Loss attributable to: The owners of the Company	(25,097)	(12,126)
Non-controlling interests	-	-
(25,097)	(12,126)

CONDENSED CONSOLIDATED INTERIM STATEMENT OF COMPREHENSIVE INCOME

For the six months ended 30 June

2017 2016

Note RMB'000 RMB'000

(Unaudited) (Unaudited)

Loss for the period (25,097) (12,126)

Other comprehensive income

Currency translation differences	(7,467)	4,510
Share of other comprehensive income of
investments accounted for using
the equity method	1,351	(165)

Items that may be reclassified subsequently to profit or loss

Other comprehensive income

for the period, net of tax (6,116) 4,345

Total comprehensive income for the period (31,213) (7,781)

Total comprehensive income attributable to:
The owners of the Company	(31,213)	(7,781)
Non-controlling interests	-	-

(31,213) (7,781)

Loss per share attributable to

the owners of the Company - Basic

and diluted (RMB) 6 (0.05) (0.02)

Dividends 7 - -

CONDENSED CONSOLIDATED INTERIM BALANCE SHEET

Note	As at 30 June 2017 RMB'000 (Unaudited)	As at 31 December 2016 RMB'000 (Audited)
ASSETS Non-current assets Property, plant and equipment	42,683	42,222
Land use rights	5,725	5,800
Intangible assets Investments accounted for using the equity method	4,439 39,478	4,612 34,586
Prepayments and other receivables	8,849	8,810
Deferred income tax assets	7,704	7,887
Other non-current assets	16,295	16,295
Total non-current assets	125,173	120,212
Current assets Inventories	80,477	90,623
Trade and notes receivables	8	199,386	184,291
Prepayments and other receivables Amounts due from customers for contract work	9	41,081 137,178	32,584 155,496
Pledged bank deposits Term deposits with initial terms of over three months	6,060 29,258	9,871 35,347
Cash and cash equivalents	240,939	286,352
Total current assets	734,379	794,564
Total assets	859,552	914,776